Enhanced plasma binding of propranolol and oxprenolol and induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the dog.
D000818:Animals; D000983:Antipyrine / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism; D004285:Dogs; D005260:Female; D006207:Half-Life; D006591:Hexobarbital / Q000378:metabolism*; D008297:Male; D010096:Oxprenolol / Q000097:blood*; D011433:Propranolol / Q000097:blood*; D011485:Protein Binding / Q000187:drug effects; D012293:Rifampin / Q000494:pharmacology*
D001798:Blood Proteins; D010096:Oxprenolol; D011433:Propranolol; D006591:Hexobarbital; D000983:Antipyrine; D012293:Rifampin